Cite
HARVARD Citation
Nirogi, R. et al. (n.d.). 0053 SUVN-G3031: Safety, Tolerability and Pharmacokinetics of a Potent and Selective Histamine H3 Receptor Inverse Agonist - Single and Multiple Ascending Doses in Healthy Subjects. Sleep. p. A22. [Online].